CKD: Medical Nutrition Therapy: Executive Summary of Recommendations (2020)
Executive Summary of Recommendations
Below are the recommendations and ratings for the Academy of Nutrition and Dietetics 2020 Chronic Kidney Disease (CKD) Medical Nutrition Therapy Evidence-Based Nutrition Practice Guideline. Use the links on the left to view the Guideline Introduction. Detailed recommendations, including the evidence supporting these recommendations, is available from the Major Recommendations tab.
- For a description of the Academy Recommendation Rating scheme (Strong, Fair, Weak, Consensus, Insufficient Evidence), click here.
- For a description of the GRADE Recommendation Rate scheme (Level 1 (1A, 1B, 1C, 1D), Level 2 (2A, 2B, 2C, 2D), click here
CKD: MNT to Improve OutcomesIn adults with CKD 1-5D, we recommend that a registered dietitian nutritionist (RDN) or an international equivalent, in close collaboration with a physician, or other provider (nurse practitioner or physician assistant), provide medical nutrition therapy (MNT). Goals are to optimize nutritional status, and to minimize risks imposed by co-morbidities and alterations in metabolism on the progression of kidney disease (1C) and on adverse clinical outcomes (OPINION).FairImperativeCKD: MNT ContentIn adults with CKD 1-5D or posttransplantation, it is reasonable to prescribe MNT that is tailored to the individuals’ needs, nutritional status and co-morbid conditions (OPINION).ConsensusImperative
Nutrition Monitoring and Evaluation
CKD: MNT Monitoring and EvaluationIn adults with CKD 3-5D or posttransplantation, it is reasonable for the registered dietitian nutritionist (RDN) or an international equivalent to monitor and evaluate appetite, dietary intake, body weight changes, biochemical data, anthropometric measurements, and nutrition-focused physical findings to assess the effectiveness of medical nutrition therapy (OPINION).ConsensusImperative
|Proceed to Guideline Overview||Return to CKD Home|